A Study to Compare Immune Response of V503 to Gardasil in 16- to 26-year-old Men (V503-020)

Clinical trial NCT02114385 · COMPLETED

Trial details

NCT number: NCT02114385
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Papilloma Viral Infection

Start date: 2014-03-24
Primary completion: 2015-04-22
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.